New tracer could enable surgeons to see and hear prostate cancer: Study Dr. Kamal Kant Kohli19 Sept 2025 11:00 PM ISTA preclinical evaluation of a new 'dual-mode' tracer agent shows promise in not only helping surgeons image and plan prostate cancer procedures, but...
Emphysema at CT lung screening increases death risk in asymptomatic adults: Study Dr. Kamal Kant Kohli19 Sept 2025 8:45 PM ISTEmphysema detected on baseline low-dose chest CT (LDCT) in the lung cancer screening cohort of more than 9,000 asymptomatic adults was associated with...
Vitamin B3 Supplement Shows Promise in Cutting Skin Cancer Risk: JAMA Medha Baranwal19 Sept 2025 8:45 PM ISTUSA: A large Veterans Affairs (VA) cohort study has found that taking nicotinamide-a vitamin B3 derivative sold over the counter-significantly lowers...
AI could soon detect early voice box cancer from the sound of your voice, suggests study Dr. Kamal Kant Kohli19 Sept 2025 8:15 PM ISTCancer of the voice box or larynx is an important public health burden. In 2021, there were an estimated 1.1 million cases of laryngeal cancer...
PET/MRI Outperforms Standard Imaging in Rectal Cancer Staging, Study Shows Medha Baranwal17 Sept 2025 9:00 PM ISTPoland: A recent prospective study published in the International Journal of Colorectal Disease has revealed that using PET/MRI instead of...
Lupin bags USFDA approval for Multiple myeloma treatment Ruchika Sharma17 Sept 2025 6:19 PM ISTMumbai: Global pharma major Lupin Limited has announced that the company has received approval from the United States Food and Drug Administration...
Merck gets USFDA Breakthrough Therapy Designation for Raludotatug deruxtecan for Platinum-Resistant Ovarian Cancer Ruchika Sharma17 Sept 2025 1:03 PM ISTRahway: Merck, Daiichi Sankyo have announced that Raludotatug deruxtecan (R-DXd) has received Breakthrough Therapy Designation (BTD) from the U.S....
FDA Approves INLEXZO for BCG-Unresponsive Bladder Cancer Dr. Kamal Kant Kohli15 Sept 2025 8:30 PM ISTThe U.S. FDA has approved Johnson & Johnson's INLEXZO (gemcitabine intravesical system) for adults with BCG-unresponsive non-muscle invasive...
Preemptive Genetic Testing Feasible for Reducing Chemotherapy Toxicity in GI Cancer, Finds Trial Medha Baranwal15 Sept 2025 8:00 PM ISTUSA: A prospective trial in gastrointestinal cancer patients found that preemptive DPYD/UGT1A1 genetic testing before chemotherapy was feasible,...
Biparametric MRI Effective as Multiparametric MRI in Detecting Prostate Cancer: Study Jacinthlyn Sylvia14 Sept 2025 9:00 PM ISTA recent study published in the Journal of the American Medical Association found biparametric MRI to performs just as well as the current...
Millions of men could benefit from faster scan to diagnose prostate cancer: JAMA Dr. Kamal Kant Kohli12 Sept 2025 8:45 PM ISTA quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer as the current 30-40 minute scan and should be rolled out to make MRI...
SOX2: a key player in prostate cancer progression and treatment resistance: Study Dr. Kamal Kant Kohli11 Sept 2025 8:00 PM ISTProstate cancer remains a global health challenge, ranking as the second most common malignancy among men. While early-stage disease can be...
